Laurie Stelzer

Laurie Stelzer currently serves as the Chief Financial Officer for Orna Therapeutics and holds board member positions at Spyre Therapeutics and PMV Pharmaceuticals, Inc. Previously, Laurie was the Chief Financial Officer at ReNAgade Therapeutics and Mirati Therapeutics, and served as an Executive Vice President and Chief Financial Officer at Arena Pharmaceuticals. Additional experience includes roles at Halozyme Therapeutics and Shire Pharmaceuticals, where responsibilities encompassed finance leadership in research and development, global investor relations, and business operations. Earlier in Laurie's career, significant contributions were made at Amgen in various finance and executive roles, including Treasurer (Acting) and Executive Director of International Business Development. Laurie's academic background includes an MBA from UCLA Anderson School of Management and a BS in Accounting from Arizona State University.